Mealey's (June 10, 2020, 8:28 AM EDT) -- SAN FRANCISCIO — E-cigarette maker Juul Labs Inc. on May 29 filed four motions challenging claims in the pending multidistrict litigation against it, seeking to dismiss all claims against it as preempted by Food and Drug Administration authority, to dismiss racketeering and state law claims against it for failure to state a claim, to dismiss 25 subclasses’ claims for lack of subject matter jurisdiction and to stay the MDL based on the FDA’s primary jurisdiction and pending premarket review of its products (In Re: Juul Labs, Inc., Marketing, Sales Practices, and Products Liability Litigation, MDL Docket No. 2913, No. 19-md-2913, N.D. Calif.)....